Technion’s Top Cancer Research

Share on:

TECHNION RESEARCH FOR A CANCER FREE WORLD

September 24th marks World Cancer  Research Day – an international awareness day to raise worldwide attention and inspire action for a cancer-free future. 

The Technion’s Integrated Cancer Center is comprised of: state-of-the-art cancer research in the Rappaport Faculty of Medicine, exceptional engineering and basic science faculties, and five affiliated medical centers – including the Rambam Health Care Campus, which is adjacent to the Rappaport Faculty of Medicine and has the largest cancer facility in northern Israel and one of the largest in the country.

Technion researchers are committed to finding new diagnostic technologies, treatments and cures to create a healthier, cancer-free future.

CURE FOR MELANOMA

Patients often fail to respond to treatments for Melanoma, the deadliest form of skin cancer. However, a team led by Technion Prof. Amir Orian and Technion lecturer Dr. Emily Avitan-Hersh found two proteins that could lead to a new approach to overcoming anti-cancer drug resistance in melanoma.

READ MORE

TREATMENT-RESISTANT CANCER GETS FUNDING BOOST

Why does cancer therapy help some patients and not others? That is a question Technion Prof. Yuval Shaked has been trying to answer with his latest medical research backed by EU funds.

READ MORE

EARLY CARDIOVASCULAR DIAGNOSIS IS THE ANSWER

According to a team of researchers headed by Technion Professor Ami Aronheim, Professor Yuval Shaked, and Dr. Shimrit Avraham, early diagnosis of heart problems in cancer patients could significantly impact treatment success.

READ MORE

BACTERIA TO FIGHT CANCER

Prof. Naama Geva-Zatorsky’s research determines that immune effects of gut bacteria can prevent cancer. Prof. Geva Zatorsky is a member of the Technion’s Rappaport Faculty of Medicine and the Technion Integrated Cancer Center.

READ MORE

 

CANNABIS:  FOR CANCER AND BEYOND

Technion Prof. Dedi Meiri is best known for his cutting-edge research into cannabis as a cancer treatment. He also investigates cannabis’ potential to treat Alzheimer’s, dementia and other neurological diseases.

READ MORE

 

COLD ATMOSPHERIC PLASMA TECHNOLOGY: THE FUTURE OF CANCER TREATMENT

Technion and Rambam Health Care Campus is progressing their research to create a Cold Atmospheric Plasma (CAP) device that can selectively fight cancer cells without damaging surrounding healthy tissue.

READ MORE

A FASTER WAY TO DIAGNOSE & PREDICT CANCER

Technion Prof. Daphne Weihs has found a way to diagnose aggressive cancer tumors in two hours. The next stage of her research is that “[they] may be able to find out more and predict where in the body a secondary tumor is likely to develop.”

READ MORE

CURING CANCER – AND SHRIMP VIRUSES

Technion Researcher Avi Schroeder is leading multiple breakthroughs to fight cancer and cure viruses. “I feel, and this is supported by research data, that in the upcoming decade, we will solve most problems with cancer treatment,” he said. “By 2030, we will reach a place where most cancer patients will be cured.” Today, he is also applying his research to find a vaccine for COVID-19.

READ MORE

PROMISING TUMOR-BUSTING TECHNOLOGY GETS FUNDED

After 10 years of funded research, aMoon, a health-tech fund,makes a $5 million investment in Technion Dean Marcelle Machluf’s venture to help bring her Nano-Ghost tumor-busting technology to market.

READ MORE

 

BLOOD TESTS IN YOUR OWN HOME

Ten years of research went into the creation of PixCell’s HemoScreen hematology analyzer. This enables cancer patients to have their blood tested at home. The patent pending, FDA-approved device is based on technology known as viscoelastic focusing, which was first discovered at the Technion.

READ MORE

 

 

With your help, Technion researchers will help create a future without cancer.  Let’s give them the tools to create a healthier tomorrow for all of us!

SUPPORT TECHNION

Flow of Light Discovery

Share on:
Distinguished Professor Mordechai (Moti) Segev

Technion scientists to an unexpected breakthrough when they became the first to observe the branching behavior of visible light. Shining a laser beam into a soap bubble, Technion President Uri Sivan and Distinguished Professor Moti Segev expected the light to lose its structure, but the light waves intensified and divided like the branches of a tree. The surprising results, featured on a recent cover of Nature, could be applied to medicine and might also further the understanding of how light flows through space and time.

READ MORE

 

 

A “Snowman” at the Edge of the Solar System

Share on:
New Horizons photograph (courtesy of NASA) of Arrokoth

A model developed at the Faculty of Physics at the Technion, in collaboration with German scientists at Tübingen, explains the unique properties of Arrokoth – the most distant object ever imaged in the solar system. The research team’s results shed new light on the formation of Kuiper Belt objects, asteroid-like objects at the edge of the Solar system, and for understanding the early stages of the solar system’s formation.

The researchers’ findings, published in the Nature, explain the unique characteristics of “the Snowman,” known formally as Arrokoth, It is the farthest imaged object in the system, and pictures of it were first taken last year by the New-Horizons space mission.

The research was led by Ph.D. student Evgeni Grishin, postdoc Dr. Uri Malamud, and their supervisor Professor Hagai Perets, in collaboration with the German research group in Tübingen.
READ MORE

 

Technion Update: Advancements Against COVID-19

Share on:

Technion – Israel Institute of Technology is at the forefront of the fight against COVID-19. Researchers from 50 different labs are developing solutions including vaccine research and therapeutics, personal protective equipment, diagnostics, and assistive technologies for healthcare providers. Despite months of hardship and uncertainty, we have witnessed the power of unity and collaboration. 

“ICU ROOM OF THE FUTURE”

Israel’s Sheba Hospital recently unveiled what they call “the ICU room of the future”. It features many innovative technologies that were developed by Technion alumni including: AnyVision, Vocalis and CLEW Medical. This room maximizes care and comfort while minimizing risk to staff during the Coronavirus pandemic.

READ MORE

UV LIGHT TO COMBAT COVID-19

Prof. Ido Kaminer

An international team of research scientists, including Prof. Ido Kaminer of the Technion-Israel Institute of Technology, advocate the use of ultraviolet light as a “particularly efficient, easily deployable, and economically affordable” way to inactivate the Coronavirus and reduce transmission in indoor spaces. Their findings were recently published in the journal ACS Nano.

READ MORE

AN ALGORITHM TO IMPROVE COVID-19 TREATMENT

Assistant Prof. Joachim Behar

Assistant Prof. Joachim Behar, head of Technion’s Artificial Intelligence Laboratory, together with Master’s student Jeremy Levy and doctors from Rambam Health Care Campus, have developed a new set of tools to analyze the data collected by oximeters, which monitor oxygen saturation levels in a patient’s blood. Information gathered by oximeters monitoring patients with COVID-19 could help doctors predict deterioration in a patient’s condition.

READ MORE

99% ACCURATE RAPID HOME TEST 

Prof. Naama Geva-Zatorsky & Team

Prof. Naama Geva-Zatorsky, of Technion’s Faculty of Medicine, is leading a team of researchers in the development of a home kit that would enable people to be quickly and inexpensively tested for the Coronavirus. Without elaborate lab equipment, it has a 99% accuracy rate based on 200 biological samples from patients affected by the virus. Today, her lab is working on improving its sensitivity for detection in low concentrations.

READ MORE

SURVEILLING SEWERS FOR COVID-19

Using the Internet of Things (IoT), original algorithms, and artificial intelligence, Israeli startup Kando, Technion-Israel Institute of Technology, and Ben-Gurion University have launched a pilot project to detect traces of the novel Coronavirus in the wastewater of Ashkelon. Kando allows experts to pinpoint specific areas affected by the SARS-CoV-2 virus, enabling responses and potentially avoiding total lock-down in the event of a second wave of the Coronavirus.

READ MORE

NANOSCENT’S BREATH TEST FOR CORONAVIRUS

Nanoscent is using nano-sensor technology and AI to diagnose patients in half a minute through breath samples. Originally tested by researchers at the Technion and the Rambam Health Care Campus back in March, trials are underway to apply this testing method to drive-through testing clinics across Israel. In addition, Magen David Adom has started using the technology at their testing stations, as have Tel Aviv Medical Center and Poriya Medical Center. Co-founder and CEO Dr. Oren Gavriely is a Technion alumnus.

READ MORE

BOOSTING MASK EFFECTIVENESS

The unique “Maya” sticker is a 3D-printed sticker, developed by the Faculty of Mechanical Engineering at the Technion-Israel Institute of Technology, led by Prof. Eyal Zussman. The innovative sticker contains nanofibers coated with antiseptics. Stuck onto surgical masks, the team says the sticker significantly upgrades protection, and is able to capture and kill nano-particles of 99 percent of viruses from droplets that reach the mask.  The next step is mass production for hospitals and the public.

READ MORE

POOLED TESTING ACCELERATES COVID-19 SCREENING

Researchers at Technion-Israel Institute of Technology announced a successful trial of pooling medical samples and performing simultaneous testing for the presence of the Coronavirus in batches of 32 or 64 samples at a time. Now, the test is undergoing final validation and it should be available for widespread use by winter, when the prevalence of other respiratory diseases will make rapid diagnosis of COVID-19 even more critical.

READ MORE

DIAGNOSTICS ROBOTICS GOES GLOBAL

Diagnostic Robotics Ltd is an AI-based remote screening platform used by Israel to monitor the spread of COVID-19. It has now been deployed globally, including in the U.S., Western Europe, and Asia. Co-founders Jonathan Amir and Dr. Kira Radinsky, and Prof. Moshe Shoham are all Technion alumni. Prof. Shoham also teaches at Technion’s Faculty of Mechanical Engineering and heads the Kahn Medical Robotics Laboratory.

READ MORE

CORTICA’S TOUCH-LESS TECH FOR A COVID-19 WORLD

Corsight, a subsidiary of the high-tech company Cortica, launched their touchless AI technology globally. Their high-speed AI facial recognition technology helps medical teams access locked areas without removing protective gear. Emerging from research at the Technion, Cortica was founded by Technion Prof. Yehoshua Zeevi and doctoral graduates, Igal Raichelgauz and Karina Ordinaev.

READ MORE

Technion breakthroughs in COVID research and technologies have been a source of inspiration and hope throughout the pandemic. When you support the Technion       COVID-19 Emergency Research Fund, you contribute to the success stories that will help us overcome this health crisis as quickly as possible.

SUPPORT THE EMERGENCY RESEARCH FUND

A Revolutionary New Battery

Share on:
Dr. Matthew Suss, Technion-Israel Institute of Technology

Groundbreaking Israeli efforts to develop an affordable, rechargeable battery to store solar and wind energy using a locally mined resource could put the country at the forefront of the world’s renewable energy revolution in less than three years.

“In a country with so much sunshine, where bromine is relatively plentiful, this project can be a catalyst for bringing Israel to where it should be, at the forefront of the renewable energy revolution,” says Dr. Matthew Suss of the Technion-Israel Institute of Technology.

READ MORE

Killing COVID with Ultraviolet Light

Share on:
Prof. Ido Kaminer

A team of international scientists, including Prof. Ido Kaminer of the Technion-Israel Institute of Technology, studied various methods to prevent coronavirus contagion in indoor spaces. Based on their findings, recently published in ACS Nano, they advocate the use of ultraviolet light as a “particularly efficient, easily deployable, and economically affordable” way to inactivate the virus.

READ MORE

Watch: Dr. Dedi Meiri – New Frontiers in Cannabis Research

Share on:

On Tuesday July 21, Dr. David (Dedi) Meiri, Ph.D – Head, Laboratory of Cancer Biology and Cannabinoid Research, Faculty of Biology and Technion Integrated Cancer Center, Technion-Israel Institute of Technology – shared his fascinating insights into the future of medical cannabis research and its role in clinical practice.

Dr. Meiri is one of the world’s foremost experts in medical cannabis research and collaborates with cannabis growers, clinicians, major manufacturers and distributors of medical cannabis for the purpose of revolutionizing cannabis treatment.  He operates the “Cannabis Database Project” and his lab is  involved in clinical trials covering diverse aspects of cannabis treatment such as colon disease, pain prevention, cancer treatment and epilepsy.

WATCH HIS PRESENTATION NOW:

 

Henry & Marilyn Taub Faculty of Computer Science

Share on:
Marilyn and the late Henry Taub z”l

In what was a highlight of the recently held virtual Technion-Israel Institute of Technology Board of Governors meeting, the University announced that its Faculty of Computer Science will henceforth be known as the Henry and Marilyn Taub Faculty of Computer Science. According to the official statement released by the Technion, the naming of the Faculty is in consideration of some six decades of leadership and financial support from the late Henry Taub, his wife Marilyn Taub, and their family foundation, including a recent decision to provide a major donation that will make possible a much-needed expansion of Technion’s Computer Science facilities, faculty and research programs.

The expansion made possible by the Taubs is of critical importance to Israel’s future, since it will directly translate into a substantial increase of high-tech employees in the workforce to match the incredible growth of the country’s tech sector.

The Family’s generosity will enable the University to improve on the already top-tier status of the Faculty of Computer Science at the forefront of global research, recruit and retain leading faculty members, expand undergraduate and graduate enrollment, and upgrade the teaching and research infrastructure.

“We are grateful to the Taub Family, whose support and engagement spans six decades,” said Technion President Professor Uri Sivan. “Since Henry Taub, of blessed memory, and his wife Marilyn, first became engaged with the Technion in the 1960s, they have been supportive and generous partners. The Faculty of Computer Science is celebrating its fiftieth anniversary, a period of remarkable achievements, and we are proud of its continued success. The most recent support from the Taub Family will help the Faculty to continue to expand and lead the field of computer science in Israel and worldwide.”

A legendary businessman who founded Fortune 500 Company Automatic Data Processing (ADP) and led it as president and chairman for many years, Henry Taub provided wise and visionary leadership to the Technion and the American Technion Society. He was recognized with the highest honors during his decades of leadership which included President of the American Technion Society and Chairman of Technion’s Board of Governors.

Mr. Taub’s first contribution was for the Morris and Sylvia Taub Computer Building, in honor of his late parents. He and Marilyn later made possible the construction of the Henry and Marilyn Taub and Family Science and Technology Center, inaugurated in 2000, and continue to support its enhancement, including a new Student Learning Center and Terrace. The Taubs’ vision and generosity were also the driving force behind the Leaders in Science and Technology Faculty Recruitment Program, which provides critical funding for state-of-the-art labs and requirements of newly recruited researchers.

In the fifty years of the Faculty of Computer Science’s existence, research has expanded and deepened, with several faculty members responsible for groundbreaking inventions, developments, and research. In 1972, the first class graduated from the Faculty with 10 students. Nearly 50 years later, a class of 300 graduates completed their baccalaureate studies.

“The Faculty is the backbone of the Israeli hi-tech industry and its graduates serve in key positions in the Israeli economy,” said Professor Dan Geiger, dean of the Henry and Marilyn Taub Faculty of Computer Science, “The Taub Family has played an important part in our development and success on a global scale. Henry Taub once said: ‘Buildings are just walls. People are what matters.’ Indeed, the generous contributions of the Taub Family will help the Faculty of Computer Science maintain and advance its leadership position in Israel’s tech-based economy.”

Overcoming Drug Resistant Melanoma

Share on:

Researchers at the Technion-Israel Institute of Technology have suggested a new approach to overcoming anticancer-drug resistance in melanoma based on the discovery of  two proteins that together play together a major role in the phenomenon.

The research, published in the Journal of Investigative Dermatology, was headed by Prof. Amir Orian (head of the lab for the study of genetic networks at the Faculty of Medicine and a member of the Technion’s Integrated Cancer Research Center of the Technion’s Rapaport Faculty of Medicine) and Dr. Emily Avitan-Hersh (a lecturer in the Technion’s Faculty of Medicine and deputy director of the dermatology department and a member of the Rambam Clinical Research Institute at Rambam Medical Center), in collaboration with Prof. Ze’ev A. Ronai of the Sanford Burnham Prebys Medical Discovery Institute in California.

READ MORE

World Brain Day

Share on:

Everyday, scientists are learning more about the miraculous human brain. Researchers are discovering innovative ways to treat and prevent neuro-degenerative disease, exploring new frontiers of psychology, and uncovering how to promote and maintain brain health.

In honour of World Brain Day on July 22, Technion Canada is highlighting some of the ground-breaking brain research taking place at the Technion-Israel Institute of Technology.  Read on to learn more about exciting discoveries and innovations in brain health!

POSITIVE EMOTIONS CAN SHRINK CANCER TUMORS

Researchers at the Technion were able to prove that positive emotions can shrink cancer tumors based on a study that involves activating the reward system in the brains of mice.

READ MORE

 

THE IMPORTANCE OF STORYTELLING FOR BABIES

Storytelling doesn’t just stimulate our imaginations. Assistant Professor Tzipi Horowitz-Kraus,  Director of the Educational Neuroimaging Center in the Faculty of Education in Science and Technology in the Technion, explains just how important this nighttime routine can be in developing the minds of babies and children.

READ MORE

 

 

NEXT GENERATION MRI

Thanks to a patented technology from Technion, the next generation of Magnetic Resonance Imaging (MRI) will help us see the bigger picture of the brain.

READ MORE

 

 MINIMIZING RISK DURING BRAIN SURGERY

Technion student Shaked Ron has invented a breakthrough technology mapping the cerebral cortex during brain surgery while minimizing risk.

READ MORE

 

GPS FOR THE BRAIN

Technion graduates, Imad and Reem Younis, developed a GPS for the brain that helps guide doctors to treat movement and psychiatric disorders in hundreds of hospital and labs around the world.

READ MORE

 

VR FOR BRAIN SURGERY REHEARSALS

Surgical Theater’s VR platform lets doctors and patients see inside the brain and rehearse for surgery. COO Alon Zuckerman, a Technion graduate, is helping build more confidence for neurosurgeons in hospitals around the United States.

READ MORE

 

SILICON CHIP TO SLOW DOWN ALZHEIMER’S

Technion researchers have found a way to slow down and possibly repair the effects of Alzheimer’s and other neuro-degenerative diseases by administering a specific protein called “neuro growth factor”.

READ MORE

 

 

SOLUTION FOR THE SLEEP CRISIS

Technion researchers have developed an AI-based technology to help accurately identify those with sleep apnea.

READ MORE

 

 

BRAIN RESEARCH TO REVOLUTIONIZE THE FIELD OF PERSONALIZED MEDICINE

Professor Itama Kahn, director of the Brain Systems Organization in Health and Disease Lab at Technion, is leading a brain research that involves identifying neurodegenerative diseases years before their effects are noticed.

READ MORE

 

 

 

Technion researchers and alumni are gaining new understanding about the complexity of our brains, and discovering new ways to treat and prevent brain-related disease. Your contribution to the Technion Fund will support neuro-science research and advancements that will improve the health of people world-wide.

DONATE NOW